Studies using α-synuclein A53T transgenic mice showed that MSA brain homogenate induced severe motor impairment and widespread α-synuclein pathology, while DLB brain homogenate produced no neurological symptoms and only localized pathological changes [373, 374]. This evidence concerns the gene SNCA and Lewy body dementia.